# A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212

> **NCT01658553** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 60 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** GSK1120212

## Key facts

- **NCT ID:** NCT01658553
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-19
- **Primary completion:** 2014-04-05
- **Final completion:** 2014-04-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01658553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01658553, "A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01658553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*